Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Craig-Hallum Initiates Coverage On scPharmaceuticals with Buy Rating, Announces Price Target of $20

Author: Benzinga Newsdesk | September 07, 2023 08:48am
Craig-Hallum analyst Chase Knickerbocker initiates coverage on scPharmaceuticals (NASDAQ:SCPH) with a Buy rating and announces Price Target of $20.

Posted In: SCPH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist